Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment

Area of Science:

• Cardiology
• Pathophysiology
• Pharmacology

Background:

• Cardiac remodeling encompasses molecular, cellular, and interstitial changes in the heart post-injury.
• These alterations affect heart size, mass, geometry, and function, often leading to poor prognosis.
• Cardiac remodeling is linked to ventricular dysfunction and malignant arrhythmias.

Purpose of the Study:

• To discuss the concepts and clinical implications of cardiac remodeling.
• To explore the pathophysiological role of various factors in cardiac remodeling.
• To describe current and future pharmacological treatment strategies for cardiac remodeling.

Main Methods:

• Literature review and synthesis of existing research on cardiac remodeling.
• Discussion of key pathophysiological factors: cell death, energy metabolism, oxidative stress, inflammation, collagen, contractile proteins, calcium transport, geometry, and neurohormonal activation.
• Categorization of pharmacological treatments into consolidated, promising, and potential strategies.

Main Results:

• Cardiac remodeling is a complex process with significant clinical implications for heart disease prognosis.
• Multiple factors including cellular stress, metabolic changes, inflammation, and neurohormonal activation contribute to remodeling.
• Pharmacological interventions are being developed and categorized based on their stage of therapeutic advancement.

Conclusions:

• Understanding cardiac remodeling is crucial for managing heart conditions and improving patient outcomes.
• Targeting the diverse pathophysiological pathways offers therapeutic opportunities.
• A multi-stage approach to pharmacological treatment is essential for addressing cardiac remodeling effectively.